Villers-lès-Nancy, 12 June 2018 - 6:30 p.m. (CET)

PRESS RELEASE

ANNUAL ORDINARY AND EXTRAORDINARY GENERAL MEETING

ON JUNE, 28, 2018

On-line Availability of Meeting Materials

The shareholders of PHARMAGEST INTERACTIVE are invited to attend the Annual Ordinary and Extraordinary General Meeting that will be held on Thursday June 28, 2018 at 5.00 pm, at headquarters located in VILLERS-LES-NANCY (54600), 5 allée de Saint Cloud.

The Preliminary Notice of Meeting, including the agenda, the draft resolutions the Board of Directors submits to the vote of the shareholders, as well as information concerning the Shareholders' Meeting attendance and voting procedures, was published in the BALO (Bulletin des Annonces Légales et Obligatoires) of May 21, 2018.

Pursuant to article R. 225-73-1 of the French commercial code, the Meeting Materials as well as the form of proxy are available on the company's web site:www.pharmagest.com,Finance, since June 7, 2018.

A convening notice to attend the meeting will be published on June 11, 2018 in the BALO, in the Official Journal "Tablettes Lorraines" and on the company's websitewww.pharmagest.com.

About PHARMAGEST Group:

Pharmagest Group is the French pharmacy information technology leader, with a market share of more than 42% and more than 1,000 employees. The Group's strategy is based on a core business of improving healthcare through information technology innovation and developing two priority areas: 1/ Services and technologies for healthcare professionals, with a focus on assisting pharmacies in patient medication compliance; and 2/ technologies for improving the efficacy of healthcare systems.

To roll out this strategy, Pharmagest Group has developed specialised businesses, including pharmacy IT, e-Health solutions, solutions for healthcare professionals, solutions for pharmaceutical laboratories, connected health devices and apps, and a sales financing marketplace.

These businesses are divided into four divisions: Pharmacy - Europe Solutions; Health and Social Care Facilities Solutions; e-Health Solutions and Fintech.

Listed on Euronext Paris™ - Compartment B

Indices: CAC® SMALL and CAC® All-Tradable par inclusion Eligible for the Long-Only Deferred Settlement Service (SRD) ISIN: FR 0012882389 - Reuters: PHA.PA - Bloomberg: - PMGI FP

For all the latest news go towww.pharmagest.com

CONTACTS

Analyst and Investor Relations:

Chief Administrative and Financial Officer: Jean-Yves SAMSON

Tel. +33 (0)3 83 15 90 67 -jean-yves.samson@lacooperativewelcoop.com

Financial Communications and Media Relations:

FIN'EXTENSO - Isabelle APRILE

Tel. +33 (0)1 39 97 61 22 -i.aprile@finextenso.fr

Attachments

  • Original document
  • Permalink

Disclaimer

Pharmagest Interactive SA published this content on 12 June 2018 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 12 June 2018 16:47:03 UTC